In addition, a potential pitfall is that PEL can be confused with T-cell lymphoma due to frequent expression of CD30 and occasional aberrant expression of CD3 in PEL (73.3% and 21.5% of cases respectively in this study). This evidence concerns the gene TNFRSF8 and T-cell non-Hodgkin lymphoma.